Executive Moves Hepion appoints renowned liver disease expert, Dr. Stephen Harrison, as consultant medical director Stephen Harrison Hepion Pharmaceuticals (NASDAQ:HEPA) appointed world-renowned Dr. Stephen Harrison as consultant medical director. Dr. Harrison is a peer-reviewer for more than 20 medical journals. He is... October 10, 2019